Clinical Trial Update: A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing oral E5501 to eltrombopag in adults with chronic immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia

Drugs mentioned

• E5501
• Eltrombopag (eltrombopag)

Snippet

Sponsor: Eisai Inc. | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: TERMINATED | Results posted: 2018-02-06